J&J Teams Up With TB Foundation To Develop New Low-cost Treatment Aimed At Asia, Africa
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Johnson & Johnson plans to work with the Global Alliance for TB Drug Development to speed up the launch of what could be the first drug in decades with a new mechanism to treat tuberculosis